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Flotillins are lipid raft-associated proteins, which
have been implicated in neuronal regeneration and in-
sulin signaling. We now show that newly synthesized
flotillin-1 reaches the plasma membrane via a Sar1-in-
dependent and brefeldin A-resistant targeting pathway.
Consistent with post-translational membrane associa-
tion of flotillin, protease sensitivity experiments suggest
that flotillin-1 is not a transmembrane protein but is
associated with the cytoplasmic face of the plasma mem-
brane. The N terminus of flotillin contains a prohibitin-
like domain (PHB), which shows homology to a number
of proteins associated with raft domains including sto-
matin, podocin, and prohibitin. We show that the PHB
domain of flotillin can efficiently target a heterologous
protein, green fluorescent protein, to the plasma mem-
brane. Another PHB-containing protein, stomatin, traf-
fics to the plasma membrane via the conventional secre-
tory pathway. Plasma membrane association of both
full-length flotillin and the green fluorescent protein-
tagged PHB domain of flotillin is dependent on palmi-
toylation and requires a conserved cysteine residue,
Cys-34, in the PHB domain. The results identify a novel
targeting mechanism for plasma membrane association
of flotillin-1 involving a Golgi-independent trafficking
pathway, the PHB domain, and palmitoylation.
The lateral association of lipids in the plasma membrane
(PM)1 of mammalian cells to form lipid microdomains has
emerged as a key concept in cell biology. These microdomains,
termed lipid rafts, have been implicated in numerous signaling
events, including T-cell activation and growth factor signaling
(1). Lipid rafts represent organized microdomains of glyco-
sphingolipids, which form a liquid-ordered phase with specific
biophysical characteristics (2, 3). Rafts were first defined by
their insolubility in non-ionic detergents and low buoyant den-
sity on sucrose gradients (4). Such detergent-insoluble lipid-
enriched domains have been shown to contain acylated pro-
teins such as Src family kinases (e.g. Fyn, Lck), multiple
glycosylphosphatidylinositol (GPI)-anchored proteins, caveo-
lins, sphingolipids, and cholesterol (5). Organized microdo-
mains of GPI-anchored proteins have been identified in the PM
of living cells (6, 7), and it is now believed that raft microdo-
mains represent a central feature of cellular organization, cru-
cial for membrane trafficking events and for specific signaling
cascades. This concept is well illustrated by the demonstration
that different Ras isoforms differ in their sensitivity to agents
which disrupt raft domains (8). Understanding how membrane
proteins associate with lipid rafts, and how they contribute to
the formation and function of these domains, is of vital impor-
tance in understanding how rafts may act to coordinate cellular
functions.
Possibly the best studied raft domain protein is the integral
membrane protein, caveolin. Caveolin is associated with a spe-
cialized form of raft domain forming a pit termed a caveola (9).
These structures perform an important role in signaling,
transendothelial transport, and lipid regulation (10–12) but
show a more restricted tissue distribution than other, biochem-
ically defined, rafts, which generally appear to be a ubiquitous
feature of eukaroytic cells (1). Caveolae and caveolins are abun-
dant in adipocytes, muscle cells, endothelial cells, and fibro-
blasts, but are rare or absent in lymphocytes and most neuro-
nal cells. More ubiquitous markers of raft domains are the
47-kDa membrane proteins of the Reggie/flotillin family (13,
14). Although both flotillin and caveolin were recently de-
scribed as novel constituents of raft domains and caveolae (14,
15), flotillin is present in cells that lack morphologically defin-
able caveolae and has been localized to non-caveolar mem-
branes (16, 17). Reggie-1 and -2 were originally identified in
regenerating neurons of goldfish optic nerves (13). They were
subsequently identified in low density detergent-insoluble com-
plexes of endothelial cells, where they were termed flotillins
(14). As well as its postulated role in neuronal regeneration,
flotilllin-1 has been implicated in insulin signaling to trigger
glucose transporter redistribution in adipocytes (18). Flotillin
also associates with phagosomes in macrophages (19).
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Flotillins contain a recently identified but largely uncharac-
terized domain, termed the prohibitin homology (PHB) domain
or SPFH domain (stomatin/prohibitin/flotillin/HflK/C domain)
(20). This domain is evolutionarily conserved and is shared by
several eukaryotic and prokaryotic membrane proteins, includ-
ing stomatin, podocin, and prohibitin, which have apparently
diverse functions. Prohibitin has been implicated in regulation
of senescence and tumor suppression (21). Mutations in podo-
cin are associated with nephrotic syndrome, which is charac-
terized by disruption of the glomerular filtration barrier (22).
Stomatin is absent in genetic disorders associated with hemo-
lytic anemia (23), although stomatin-deficient mice do not show
the same phenotype (24). Interestingly, despite PHB domain
proteins showing differences in intracellular localization, with
prohibitin largely mitochondrial (25) and the other proteins PM
localized, several members of the family have been reported to
associate with low density detergent-insoluble lipid raft do-
mains (25–27). The role of the PHB domain, which has hydro-
phobic stretches but no classical transmembrane domain, is
unknown. However, a recent study concluded that flotillin is a
type I transmembrane protein with a hydrophobic region in the
PHB domain of flotillin acting as a transmembrane domain
(28). In contrast, both stomatin and podocin have been shown
to form a hairpin conformation with both N and C termini
cytoplasmic (29, 30). Podocin, stomatin, and prohibitin, al-
though showing homology with flotillins in the PHB domain,
differ in having a well defined hydrophobic putative intramem-
brane domain to the N-terminal side of the PHB domain.
In this study we have investigated the topology of flotillin,
the mechanisms by which Reggie-2/flotillin-1 reaches the PM,
and examined the possible role of the PHB domain in mem-
brane association. We now show that, although flotillin be-
haves as an integral membrane protein, it can reach the PM via
a Sar1-independent, brefeldin A (BFA)-insensitive pathway. In
contrast, stomatin trafficking is through the conventional se-
cretory pathway. The PHB domain of flotillin constitutes a
novel lipid recognition motif, which can target a heterologous
protein, GFP, to the PM. Association with the PM is dependent
on palmitoylation and requires a key conserved cysteine resi-
due close to the N terminus of the protein. These studies reveal
a novel pathway for palmitoylation-dependent association of a
protein with raft domains.
MATERIALS AND METHODS
Cell Culture and Transfection—Baby hamster kidney (BHK) cells
and Vero cells (African green monkey kidney cells) were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10% (v/v) se-
rum supreme (BioWhittaker, Walkersville, MD) and 2 mM L-glutamine
plus or minus penicillin (100 units/ml) and streptomycin (100 g/ml).
BHK and Vero cells were transiently transfected using LipofectAMINE
2000 or LipofectAMINE Plus reagent (Invitrogen) according to the
instructions from the manufacturer.
Antibodies and Other Reagents—Rabbit anti-flotillin-1 antibodies
were raised against a synthetic peptide (Mimotopes, Adelaide, Austra-
lia) corresponding to the C terminus of mouse flotillin (VNHNKPLRTA)
with the addition of a cysteine residue at the N terminus for coupling to
a carrier protein or for preparing an affinity purification column (19).
Affinity purification was performed exactly as described previously (31).
Antibodies were obtained from the following sources: mouse anti-
Na/K ATPase (Upstate Biotechnology, Inc., Lake Placid, NY); mouse
anti-flotillin-1, rabbit anti-caveolin-1, and mouse anti-GM130 (Trans-
duction Laboratories, Lexington, KY); rabbit anti-myc and rabbit anti-
hemagglutinin (HA) (Dr. Tommy Nilsson, European Molecular Biology
Laboratory, Heidelberg, Germany); and rabbit anti-GFP (32). Brefeldin
A, Triton X-100, and 2-bromopalmitate (2-bromo-hexadecanoic acid)
(2BP) were purchased from Sigma Aldrich, proteinase K from Roche
Diagnostics (Mannheim, Germany), and dextran-FITC from Molecular
Probes (Eugene, OR). Media and cell culture reagents were purchased
from Invitrogen or BioWhittaker.
Generation of Constructs—The following primers (5-CGC GGA TCC
GCT TCA ACC ATG TTT TTC ACT TGT GGC-3 and 5-GG ACA TGC
ATG CGG GCT CAT GCT GTC CTT AAA GGC-3) were used to PCR-
amplify nucleotides 151–1453 of the published mouse flotillin cDNA
sequence (14) from a 3T3-L1 adipocyte ZAP cDNA library. The result-
ing product was cloned into the BamHI and SphI sites of pUC19 to form
pUC19/flotillin. The authenticity of the cloned sequence was confirmed
by sequencing. A BamHI-HindIII fragment was then excised from
pUC19/flotillin and cloned into BglII-HindIII sites of pCB6 to generate
pCB6/flotillin.
Wild type flotillin was cloned into pBluescript SK (Stratagene, La
Jolla, CA) and used as a template to generate an internally HA-tagged
flotillin in two parts. The following primers, T3 and 5-GGC GTA ATC
GGG GAC GTC ATA AGG GTA GGA CCC TCC ACT AGA CAC CAG
CGT GAT CTT ATT GGC TGA GG-3, were used in one PCR reaction to
produce the left flank of flotillin with an HA tag, and 5-TAC CCT TAT
GAC GTC CCC GAT TAC GCC GGG GGG AGC GGA ACC ATG GGG
GCA GCC AAA GTT ACT GGG G-3 and T7 were used in a second
reaction to produce an HA-tagged right flank. The two halves of flotillin
were ligated together by utilizing an AatII site naturally occurring
within the HA tag and cloned into pC1 (pEGFP C1 (Clontech, Palo Alto,
CA) minus GFP). f-PHB-GFP was generated using pBluescript/flotillin
as template and employing standard PCR techniques. The PCR product
was cloned into the eukaryotic expression vector pEGFP N1 (Clontech).
Flot-C34A-HA and f-PHB-C34A-GFP were made by applying a stand-
ard site-directed mutagenesis approach employing Flot-HA and f-PHB-
GFP as templates, respectively. The authenticity of all constructs was
confirmed by sequencing. The following plasmids were kind gifts: GFP-
GPI (Chiara Zurzolo, Dipartimento di Biologia e Patologia Cellulare e
Molecolare, Naples, Italy), and Sar1(H79G) (Rainer Pepperkok, Euro-
pean Molecular Biology Laboratory, Heidelberg, Germany). GFP-tH
and stomatin-myc have been previously described (32, 33).
Light and Electron Microscopy—For immunofluorescence studies,
cells were routinely fixed with 4% paraformaldehyde and immunola-
beled according to Luetterforst et al. (34). For immunoelectron micros-
copy studies, BHK cells were transfected with the cDNA for flotillin-1.
PM sheets were prepared as described previously (32) and labeled with
rabbit antibodies to the C terminus of flotillin-1 followed by 10-nm
protein A-gold.
Biochemical Procedures—Protein samples were analyzed by SDS-
polyacrylamide gel electrophoresis, and Western blotting was per-
formed as described previously (34).
Carbonate Treatment—Crude membrane fractions were prepared
from BHK cells as described previously (34) and treated with 150 l of
either 0.1 M NaCO3 (pH 11.5) or HES buffer (pH 7.4) for 15 min on ice.
Protease Sensitivity Experiments—6-cm dishes of transfected BHK
cells were washed with PBS and incubated at 37 °C with 1 ml of either
500 g/ml proteinase K in PBS, 500 g/ml proteinase K plus 0.01%
Triton X-100 (v/v) in PBS, 0.01% Triton X-100 in PBS only, or PBS only
for 30min. 100 l of 100 mM PMSF was added to each dish, and cells
were scraped and collected for centrifugation to pellet membranes at
75,000 rpm at 4 °C for 30min in a TLA100.4 rotor. Membranes were
resuspended in 150 l of ice-cold homogenization buffer (10 mM Tris
(pH 7.5), 150 mM NaCl, 5 mM EDTA) and sonicated prior to assaying
each sample for protein concentration.
Sucrose Density Gradients—Transfected BHK cells were washed
twice with ice-cold PBS and scraped into 250 l of homogenization
buffer plus 1% Triton X-100 and protease inhibitors. Cells were passed
10 times through a 25-gauge needle and centrifuged to pellet nuclei and
unbroken cells. 300 l of the supernatant was mixed with an equal
volume of 90% (w/v) sucrose and loaded into a centrifuge tube. The load
fraction was overlaid with 228 l each of 35, 30, 25, 20, 15, 10, and then
5% sucrose and centrifuged at 50,000 rpm in a TLS-55 rotor at 4 °C for
16 h. 11 equal fractions of 150 l were collected from the top of the
gradient, and 1 fraction of 600 l representing the load fraction. Equal
volumes of each fraction were analyzed by Western blotting.
Biosynthetic Labeling and Immunoprecipitation—To measure incor-
poration of palmitate, transfected BHK cells were incubated for 2 h at
37 °C with 250 Ci/ml [9,10-3H]palmitate (PerkinElmer Life Sciences)
in CO2-independent media containing 20 mM L-glutamine and 3.5
mg/ml fatty-acid free bovine serum albumin  100 M 2-bromopalmi-
tate. Cells were washed three times with IP buffer (50 mM Tris-HCl (pH
8.0), 150 mM NaCl, 5 mM EDTA) then lysed for 30 min at 4 °C in 500 l
of IP buffer containing 1% Nonidet P-40, 0.1% SDS, and protease
inhibitors. Cells lysates were cleared by microcentrifugation at 14,000
rpm for 15 min. The volume of cleared lysate was adjusted to 1 ml using
IP buffer plus 1% Nonidet P-40. Affinity-purified mouse anti-HA or
rabbit anti-GFP antibodies were added overnight at 4 °C followed by
protein A/G-agarose for 2 h. Immunoprecipitated proteins were washed
twice with IP buffer plus 1% Nonidet P-40, then twice with PBS, and
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resolved immediately by 12% SDS-PAGE. Gels were incubated in Am-
plify (Amersham Biosciences) 15–30 min, dried, and analyzed by fluo-
rography. To determine transfection and immunoprecipitation effi-
ciency, equivalent plates of cells were incubated in parallel in the
absence of [3H]palmitate and the level of transfected proteins deter-
mined by Western blotting. To verify that the radiolabeled fatty acid
incorporated into flotillin/PHB was linked by a thioester bond, suscep-
tibility to hydroxylamine was examined as described previously (35).
Microinjection—Vero cells were injected with the indicated cDNAs as
described previously (36). In Sar1 experiments, cells were injected with
the cDNAs for Sar1(H79G) plus dextran-FITC (to indicate successful
injection) and then 4 h later were injected with the Flot-HA or GFP-GPI
cDNAs. In BFA and 2-bromopalmitate experiments, Vero cells were
microinjected in the presence or absence of either 5 g/ml BFA or 100
M 2-bromopalmitate and were cultured for 5 h after injection under the
same conditions.
RESULTS
Expressed Flotillin Is Targeted to the Plasma Membrane in
Cultured Cells—To investigate the trafficking of flotillin-1, un-
tagged mouse flotillin-1 was expressed in BHK cells or Vero
cells and detected by immunofluorescence using affinity-puri-
fied antibodies against the C terminus of the protein (19). As
shown in Fig. 1 (A and B), expressed flotillin was predomi-
nantly associated with the PM. Although BHK cells have en-
dogenous flotillin-1 (see Fig. 4E), untransfected cells show neg-
ligible labeling by immunofluorescence under the same
conditions. To determine the distribution of flotillin-1 within
the PM, we used immunoelectron microscopy on PM sheets as
described previously (37). With this method caveolae are
clearly evident as uncoated circular profiles associated with the
PM (Fig. 1D). Specific labeling for flotillin was associated with
the inner surface of the PM. Labeling was mainly associated
with featureless PM, sometimes in clusters, but low levels of
labeling were associated with caveolae. Quantitation showed
that 10% of PM flotillin was associated with caveolae. As
caveolae occupy 3.5% of the PM in BHK cells (38), this sug-
gests a slight concentration of flotillin-1 in caveolae as com-
pared with the bulk PM.
Flotillin Reaches the Plasma Membrane via a BFA and Sar1-
independent Trafficking Pathway—We next investigated the
use of epitope-tagged forms of flotillin-1 to facilitate the study
of flotillin-1 trafficking to the PM. GFP tagging at either the N
or C terminus caused intracellular retention of flotillin in large
perinuclear aggregates, possibly aggresomes (results not
shown). Even small epitope tags such as N-terminal HA and
C-terminal myc tags caused similar perturbation of flotillin-1
trafficking (results not shown). We therefore introduced an
internal HA tag proximal to the C terminus between Ser-385
and Gly-386 in a region with low sequence conservation in the
flotillin/stomatin family of proteins. The HA-tagged protein,
here termed Flot-HA, was efficiently transported to the PM in
an identical fashion to the wild type untagged protein (Fig. 1C).
We also examined whether the epitope-tagged protein showed
similar behavior to the untagged protein with respect to its
association with detergent-resistant low density raft domains.
The expressed untagged protein, Flot-HA, and endogenous flo-
tillin all showed similar sedimentation characteristics after
detergent treatment and flotation analysis (see Fig. 4E).
Most transmembrane proteins are inserted into the endo-
plasmic reticulum (ER) membrane via a signal peptide. Those
destined for the PM first traverse the Golgi en route to their
final destination. To determine whether flotillin follows this
pathway, we investigated whether flotillin is transported to the
PM via the Golgi complex, or by a Golgi-independent pathway
such as that followed by K-Ras (39). We employed a number of
well characterized agents to specifically disrupt the Golgi traf-
ficking pathway. As a positive control, we utilized a GPI-an-
chored form of GFP (GFP-GPI), which is transported via vesic-
ular transport through the Golgi complex to the PM (40). We
first used BFA, which disassembles the Golgi complex and
prevents anterograde transport through the secretory path-
way. BFA caused a complete block of GFP-GPI transport to the
PM (Fig. 2, D–F). Using an identical expression protocol, PM
localization of Flot-HA was shown to be completely unaffected
by BFA treatment (Fig. 2, J–L).
As an independent test of Golgi involvement in flotillin traf-
ficking to the PM, we used a dominant negative GTP-restricted
mutant of Sar1 (Sar1(H79G)). Sar1 GTPase regulates Cop II
assembly, and expression of Sar1(H79G) has been shown to
inhibit ER to Golgi transport (45). The cDNA encoding
Sar1(H79G) was injected into Vero cells together with dextran-
FITC to mark expressing cells as in previous studies (36). The
same cells were then injected with either the cDNA for GFP-
GPI or with the cDNA encoding Flot-HA. Whereas GFP-GPI
transport to the PM was completely blocked in cells co-express-
ing Sar1(H79G) (Fig. 2, M–O), Flot-HA transport to the PM
was completely unaffected (Fig. 2, P–R). These results show
that flotillin and GPI-anchored proteins reach the PM using
different mechanisms and that flotillin transport to the PM
does not require exocytic transport from the ER to the Golgi
complex.
Flotillin Topology; Flotillin-1 Adopts a Cytoplasmic Orienta-
tion—Flotillin has been shown to associate with the Golgi com-
plex and was proposed to be a transmembrane protein with an
N-terminal extracellular/luminal and a transmembrane do-
main between amino acids 134 and 151 (28). In that study a
14-kDa fragment of flotillin was protected from digestion of
Golgi membranes with proteinase K. We have previously
shown that the C terminus of the protein is cytoplasmically
exposed (19) but were unable to detect any part of the protein
exposed extracellularly by labeling the surface of non-perme-
FIG. 1. Flotillin is targeted to the plasma membrane in cul-
tured cells. Vero cells (A and C) and BHK cells (B and D) were
transiently transfected with untagged mouse flotillin-1 (A, B, and D) or
flotillin-1 with an internal HA tag proximal to the C terminus (C). By
immunofluorescence microscopy, flotillin-1 was observed to target effi-
ciently to the PM (A–C). Panel D is a representative field showing
immunoelectron microscopic detection of expressed flotillin-1 on a PM
sheet (D). Flotillin-1 was detected using anti-flotillin antibodies fol-
lowed by 10-nm protein A gold. The majority of the gold particles are
associated with featureless PM. Some gold labeling is associated with
caveolae (double arrows), but many caveolae are unlabeled (single ar-
rows). Some clusters of flotillin on non-caveolar membranes are appar-
ent (arrowheads). Neighboring untransfected cells showed negligible
labeling (results not shown). Bars, 10 m (A–C) and 200 nm (D).
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abilized cells at 4 °C with available antibodies (results not
shown). We therefore tested whether the flotillin-1 N-terminal
domain is exposed extracellularly by expressing flotillin (data
not shown), or Flot-HA, in BHK cells and then treating cells
with proteinase K in the presence or absence of detergent.
Caveolin, which in BHK cells has no detectable extracellular
domain (38), was used as a control for cell permeability. As
shown in Fig. 3, neither Flot-HA nor caveolin showed a detect-
able change in mobility upon treatment with extracellular pro-
teinase K. In contrast, a combined treatment with proteinase K
and detergent caused a total loss of flotillin immunoreactivity
and loss of full-length caveolin. Thus, flotillin-1, like caveolin,
has no proteinase K-sensitive extracellular domain.
The PHB Domain of Flotillin-1 Is Sufficient for Membrane
Association of a Heterologous Protein—The above results sug-
gested that flotillin may be produced as a soluble protein,
which subsequently associates with the PM. We therefore in-
vestigated the means of membrane anchoring of the flotillin
protein and investigated the possibility that the N-terminal
portion of the protein, containing the PHB domain or SPFH
domain, can target an unrelated cytosolic protein, GFP, to the
PM. As the exact boundaries of the domain are difficult to
define, we generated a series of fusion proteins, PHB1–PHB6,
which comprised the N-terminal regions of flotillin fused to the
N terminus of GFP (shown schematically in Fig. 4A). Upon
expression in BHK cells, PHB1-, 3-, 4-, 5-, and 6-GFP showed
varying levels of cytosolic or possible aggresomal labeling (re-
sults not shown). However, PHB2-GFP, corresponding to
amino acids 1–237 (subsequently termed f-PHB-GFP for flotil-
lin-PHB-GFP fusion protein), was efficiently transported to the
PM in both Vero and BHK cells (Fig. 4, B and C, respectively).
This was confirmed biochemically; both f-PHB-GFP and flotil-
lin were predominantly present in the membrane fraction after
a high speed spin to remove cytosolic proteins (Fig. 4D). To
remove peripheral membrane proteins, the membranes were
treated with sodium carbonate (pH 11.5). Flotillin and f-PHB-
GFP were unaffected by carbonate treatment, showing that
both proteins behave as integral membrane proteins (Fig. 4D).
We next tested whether the PHB domain of flotillin was able to
confer raft association on GFP as judged by association with
low density Triton X-100-insoluble membranes at 4 °C. As
shown in Fig. 4E, f-PHB-GFP showed significant association
with low density fractions. However, this was consistently a
smaller fraction of the total protein than with endogenous
flotillin-1 or expressed flotillin-1 (tagged or untagged).
To investigate whether the f-PHB domain reaches the PM
using a similar pathway to flotillin, we tested whether f-PHB-
GFP also reaches the PM in a Golgi-independent manner. As
shown in Fig. 5 (D–F), f-PHB-GFP targeting to the PM is
completely resistant to BFA treatment. Real-time microscopy
of living cells expressing f-PHB-GFP showed association of
f-PHB-GFP with the PM within 45 min after intranuclear
injection of the cDNA (results not shown). No evidence of ER
localization was ever seen for the f-PHB-GFP, unlike caveolin-
GFP, but some Golgi labeling was observed. The significance of
this is presently unknown but could indicate the existence of an
alternative pathway for flotillin-1 trafficking.
FIG. 2. Trafficking of nascent Flot-HA to the plasma mem-
brane is insensitive to disruption of ER/Golgi transport. Vero
cells were microinjected with GFP-GPI (A–F) or Flot-HA (G–L), in the
presence (D–F and J–L) or absence (A–C and G–I) of 5 g/ml BFA and
incubated for 5 h with or without BFA prior to fixation. Treatment with
BFA disrupted the Golgi complex, as revealed by immunolabeling for
the Golgi marker GM130 (E and K). GFP-GPI localization at the PM
was disrupted by treatment with BFA (D). In contrast, Flot-HA local-
ized to the PM in both absence (G) and presence (J) of BFA. To confirm
that trafficking of Flot-HA to the PM was insensitive to Golgi disrup-
tion, Vero cells were injected with Sar1(H79G) plus dextran-FITC and
incubated for 4 h at 37 °C to allow protein expression. The same cells
were subsequently injected with either GFP-GPI or Flot-HA and incu-
bated for another 5 h at 37 °C. GFP-GPI was detected by labeling for the
GFP tag with anti-GFP, followed by goat anti-rabbit-cy3 (to allow
detection of both dextran-FITC and GFP-GPI in different channels).
GFP-GPI was absent from the PM of cells co-injected with Sar1(H79G)
(asterisks; M), detected by the presence of dextran-FITC (N). However,
GFP-GPI-injected cells without Sar1(H79G) injections show a typical
PM localization. In contrast, cells injected with Flot-HA (P) show cell
surface labeling regardless of the presence (asterisks), or absence, of
Sar1(H79G) expression. Bars, 10 m.
FIG. 3. Flotillin-HA is insensitive to proteinase K degradation
in non-permeabilized cells. BHK cells were transiently transfected
with Flot-HA for 24 h and then incubated with 500 g/ml proteinase K
(lane 1), 500 g/ml proteinase K plus 0.1% Triton X-100 (lane 2), 0.1%
Triton X-100 (lane 3), or PBS (lane 4) for 30 min. Both Flot-HA and
caveolin were unaffected by proteinase K digestion in intact cells (lane
1). In contrast, no Flot-HA labeling is evident and caveolin-1 has been
partially degraded after proteinase K treatment of permeabilized cells
(lane 2). These results suggest that no significant portion of flotillin is
accessible to extracellular proteinase K.
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Finally, we investigated whether trafficking to the surface
via a Golgi-independent pathway is a feature of other PHB-
domain containing proteins. Stomatin is a related PHB-con-
taining PM protein, which also associates with raft domains.
Unlike flotillin-1, PM association of stomatin is strongly af-
fected by BFA treatment (Fig. 5, J–L), showing that it is traf-
ficked in a Golgi-dependent manner. Sequence alignments of a
number of proteins containing the PHB motif show that stom-
atins fall within a distinct class of proteins (including stomatin,
podocin, Mec2, Unc-1, and Unc-24), all of which contain a
putative, N-terminal hairpin-like, intramembrane domain that
is not present in the flotillin family (Fig. 6A). This domain may
confer cotranslational insertion into the ER, and this suggests
that the PHB domain may function in the context of both
transmembrane proteins and cytoplasmic membrane-associ-
ated proteins.
Palmitoylation within the PHB Domain Is Involved in Flo-
tillin-1 Association with the Plasma Membrane—The flotillin-
related PM protein, stomatin, is palmitoylated at two sites in
the N terminus of the protein (30). The region containing the
major palmitoylation site in stomatin, Cys-29 (human), is lack-
ing in flotillin-1 (Fig. 6A), but a second palmitoylated cysteine
residue, Cys-85, is conserved (corresponding to Cys-34 in flo-
tillin-1). Cys-34 is the only cysteine in flotillin-1 that is highly
conserved among PHB domain-containing proteins and in flo-
tillin-1 is evolutionarily conserved down to the goldfish, Car-
assius auratus. Hence, we investigated first whether flotillin-1
is palmitoylated, and second whether palmitoylation plays a
role in association with the PM.
Cells were transfected with Flot-HA or f-PHB-GFP and then
incubated with [3H]palmitate for 2h. Flot-HA or f-PHB-GFP
were specifically immunoprecipitated using antibodies to the
HA or GFP tag, respectively. Labeling was specifically incor-
porated into both Flot-HA and PHB-GFP (Fig. 6B). Incorpora-
tion of label was hydroxylamine-sensitive and was greatly
reduced by treatment with the specific inhibitor of palmitoyla-
tion, 2BP (41) (Fig. 6C). Incorporation of label was completely
abolished by mutation of Cys-34 to Ala to create f-PHB-C34A-
GFP (Fig. 6D), suggesting that Cys-34 is the major palmitoy-
lation site in the PHB domain (which contains all the cysteine
residues in flotillin-1). As well as identifying the major palmi-
toylation site in flotillin-1, these results strengthen our pro-
posed model for the topology of flotillin-1 with both N and C
termini cytoplasmically orientated.
We employed two strategies to investigate the role of palmi-
toylation in flotillin localization. We first treated cells with the
palmitoylation inhibitor, 2BP. As a positive control we used
GFP-tH, a dually palmitoylated and farnesylated protein that
comprises the PM targeting information of H-Ras fused to GFP
(39). Treatment with 2BP inhibited association of palmitoy-
FIG. 4. The PHB domain of flotillin-1 is sufficient to target a
heterologous protein to the plasma membrane. A series of trun-
cation mutants of flotillin were fused to the N terminus of GFP. Their
positioning relative to full-length flotillin-1 is represented in a sche-
matic (A), which also shows the two hydrophobic domains (shaded
rectangles), the putative PHB domain, and SPFH domain. Of these
constructs, PHB-2 GFP (asterisk), subsequently called f-PHB-GFP, was
found to target to the PM in Vero and BHK cells (B and C, respectively)
with some evidence of possible aggresomal localization (puncta). f-PHB-
GFP and flotillin are predominantly associated with the membrane
pellet after high speed centrifugation of transfected BHK cells in the
presence or absence of sodium carbonate (pH 11.5) treatment (D).
Overexpressed wild type flotillin and Flot-HA show similar sedimenta-
tion characteristics to endogenous flotillin and caveolin after Triton
X-100 treatment and flotation in a 5–45% sucrose gradient (E). f-PHB-
GFP shows a greater proportion of protein floating than a soluble
protein, GFP, and a non-raft membrane protein, Na/K ATPase. How-
ever, a smaller percentage of total f-PHB-GFP floats to the lower
density sucrose fractions than seen with full-length flotillin. Bars, 10
m.
FIG. 5. Trafficking of nascent f-PHB-GFP to the plasma mem-
brane is insensitive to BFA treatment. Vero cells were microin-
jected with f-PHB-GFP (A–F) or stomatin-myc (G–L) in the presence
(D–F and J–L) or absence (A–C and G–I) of 5 g/ml BFA and incubated
for 5 h with or without BFA prior to fixation. The PM localization of
f-PHB-GFP was not perturbed by BFA treatment (D–F), unlike stoma-
tin, which was strongly affected (J–L). Bars, 10 m.
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lated GFP-tH protein with the PM (Fig. 7, A and B) but had no
effect on the trafficking of GFP-GPI (Fig. 7, C and D), confirm-
ing the specificity of the agent. Treatment with 2BP caused a
significant disruption of f-PHB-GFP association with the PM
(Fig. 7F). Similar results were observed in cells injected with
Flot-HA with greatly reduced PM staining (data not shown).
We then investigated the localization of f-PHB-C34A-GFP. The
mutant protein showed greatly decreased association with the
PM, as judged by immunofluorescence and by membrane frac-
tionation (Fig. 7, H and I). We tested the effect of the same
mutation within the context of the full-length flotillin protein.
Flotillin-C34A-HA showed a greatly decreased association with
the PM with significant accumulation of the protein intracel-
lularly (Fig. 7, G and I). Thus, the PHB domain of flotillin-1 can
mediate association with the PM, and this requires palmitoy-
lation of Cys-34.
DISCUSSION
In the present study, we have investigated the mechanism by
which the raft-associated flotillin-1 protein accesses the PM
and associates with specific surface domains. We have shown
that association with the PM occurs in a Golgi-independent
manner. The results identify a role for the PHB domain and
palmitoylation in membrane targeting and have implications
for a large family of PHB-containing proteins including stoma-
tin and podocin.
Our results strongly support the hypothesis that flotillin-1
associates with the cytoplasmic face of the PM in an orientation
similar to both stomatin and podocin. Previous studies showed
protection of a 14-kDa N-terminal fragment of flotillin-1 upon
protease treatment of Golgi vesicles, and this was interpreted
as indicative of transmembrane orientation of flotillin with the
N terminus exoplasmic/luminal (28). We speculate that the
protection of a fragment of flotillin may instead reflect inser-
tion of part of the PHB domain into the membrane and that
flotillin associates with the inner face of the membrane. First,
PM flotillin is unaffected by surface protease treatment. Sec-
ond, we provide strong evidence for palmitoylation of the N
terminus of flotillin and a role for palmitoylation in membrane
association. Consistent with this, previous studies described
dissociation of flotillin from the membrane upon hydroxyla-
mine treatment of membranes to disrupt palmitoylation (13).
Finally, we have shown that both full-length flotillin and an
N-terminal domain of flotillin associate with the PM in a Golgi-
independent manner, more consistent with post-translational
association with membranes than cotranslational insertion of a
transmembrane domain into the ER.
Although these studies suggest that PHB-domain-containing
proteins such as flotillin and stomatins share a cytoplasmic
orientation in the membrane, with both N- and C termini
cytoplasmic (29, 33), a striking difference between flotillins and
stomatin-like proteins (stomatin, podocin, prohibitin) is the
presence of a highly hydrophobic putative intramembrane re-
gion in stomatin-like proteins which is absent in flotillins (Fig.
6A). This long hydrophobic segment may act as an uncleaved
FIG. 6. Palmitoylation of flotillin. A,
Cys-34 is highly conserved within the PHB
domain of the stomatin family. A ClustalW
alignment was performed with flotillin-1
(human, accession no. 075955), flotillin-1
(mouse, AH04647), reggie2b (goldfish,
AK07568), podocin (human, Q9NP85),
MEC2 (Caenorhabditis elegans, AAA82333),
hUNC24 (human, AAD42031), UNC24 (C.
elegans AAC02604), Unc-1 (C. elegans,
T34324), stomatin (human, AAA58432), and
stomatin (mouse, AAC64173). The two
palmitoylation sites in stomatin are indi-
cated (boxed regions with asterisks). The ma-
jor palmitoylation site at position 29 in sto-
matin (30) is absent in flotillin-1; the minor
palmitoylation site in stomatin (Cys-85) is
conserved in several PHB-containing pro-
teins including flotillin-1 (Cys-34). Flotillin-1
lacks the hydrophobic stretch of amino acids
comprising the putative intramembrane do-
main of stomatin (broken line). Numbering
above the alignment indicates amino acid
position in flotillin-1 (human); numbering
below indicates amino acid position in sto-
matin (mouse). B–D, palmitoylation of flotil-
lin. BHK cells were transfected with either
Flot-HA or f-PHB-GFP and then were la-
beled with [3H]palmitate for 2h. They were
subsequently immunoprecipitated with an-
tibodies specific for their epitope tags.
[3H]Palmitate was specifically incorporated
into both Flot-HA and f-PHB-GFP (which
contains all the Cys residues in flotillin).
Note that transfection efficiency was lower
with Flot-HA giving rise to the lower signal.
Samples treated with hydroxylamine to dis-
rupt thioester linkages show a striking de-
crease in [3H]palmitate signal when com-
pared with untreated samples (B).
Incorporation of [3H]palmitate was also
found to be significantly reduced upon treat-
ment with 2BP in f-PHB-GFP-transfected
cells (C). No [3H]palmitate was incorporated
into f-PHB-C34A-GFP compared with f-
PHB-GFP, even though equal loading of pro-
tein was evident in the IP (D; anti-GFP).
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signal sequence for insertion into the ER, as suggested for
caveolin-1, which also adopts a hairpin-like conformation in the
membrane (42). This may give rise to the different trafficking
pathways followed by the stomatin-like proteins and flotillin-1.
As shown here, stomatin trafficking, unlike flotillin trafficking,
is dependent on the Golgi complex.
The flotillin PHB domain possesses information for targeting
a heterologous protein, GFP, to the PM and, like the full-length
protein, does so via a Golgi-independent trafficking pathway.
Thus, flotillin targeting, like that of K-Ras (39), occurs in a
BFA- and Sar1-insensitive manner. In contrast, the trafficking
of other PM proteins, such as H-Ras and GPI-anchored pro-
teins, are both completely blocked by these agents (this study
and Ref. 39). For both K-Ras and flotillin, the mechanisms
involved and the role of possible chaperoning proteins remain
to be elucidated. Although our studies identify a Golgi-inde-
pendent trafficking pathway, which can be followed by flotil-
lin-1 upon Golgi disruption, they do not rule out the trafficking
of flotillin-1 by more than one pathway. In fact, at early times
of expression, we observed significant association of f-PHB-
GFP with the Golgi complex as identified by colabeling with the
Golgi marker GM130 (results not shown). This raises the pos-
sibility that flotillin can use the conventional secretory path-
way, at least partially, to reach the PM. This is consistent with
a report of Golgi association of flotillin-1 (28).
On reaching the PM, flotillin and the f-PHB-GFP fusion
protein are associated with the PM in a sodium carbonate-
resistant manner, arguing for tight association with the mem-
brane, presumably via one or both hydrophobic segments in the
PHB domain of flotillin, rather than peripheral association
with PM proteins or co-association with endogenous flotillin.
The PHB domain is present within a diverse family of eukary-
otic proteins, which are not all PM-associated, suggesting that
differences in this domain, or in targeting pathways, might
dictate the cellular location of the proteins. Intriguingly, even
though these proteins have distinct destinations in the cell,
they have been shown to associate with raft domains as deter-
mined biochemically. The archetypal member of the family,
prohibitin, associates with mitochondria but was isolated in
detergent-insoluble floated fractions from epithelial cells (25).
Podocin and stomatin have also been shown to associate with
raft domains (26, 27). It is therefore interesting to speculate
that the PHB domain itself confers raft association. We find
that the flotillin-PHB domain shows affinity for raft domains,
as shown by the usual criteria of detergent insolubility and
flotation in sucrose density gradients, but does not show the
same high level of raft association as flotillin. Other properties
of flotillin, such as oligomerization mediated by the coiled coil
domain of the protein, outside the PHB domain, may be
involved.
Our studies also suggest a role for palmitoylation in associ-
ation of flotillin, and the PHB domain, with the PM. An inhib-
itor of palmitoylation reduced association of newly synthesized
flotillin with the PM. Mutation of the conserved cysteine resi-
due, Cys-34, in the N terminus of the protein greatly reduced
labeled palmitate incorporation into flotillin and also inhibited
PM association. The compartment in which palmitoylation
takes place remains to be determined. Although the role of
palmitoylation in raft association of membrane proteins is well
established (43), the best studied pathway by which palmitoy-
lated raft proteins reach the PM involves palmitoylation in the
ER and then transport on the cytoplasmic surface of mem-
branes of the secretory pathway to the cell surface. H-Ras, for
example, is still palmitoylated when ER to Golgi traffic of
newly synthesized H-Ras is inhibited by BFA (39). In contrast,
K-Ras accesses the PM using an alternative, Golgi-independ-
ent pathway (39, 44).
In conclusion we have shown that the PHB/SPFH domain of
flotillin possesses membrane targeting activity, which can con-
fer raft association on a heterologous protein. The PHB/SPFH
FIG. 7. Plasma membrane localization of f-PHB-GFP requires
palmitoylation of Cys-34. Vero cells were injected with GFP-tH (A
and B), GFP-GPI (C and D), or f-PHB-GFP (E and F) and subsequently
incubated at 37 °C for 5 h in the presence (B, D, and F) or absence (A,
C, and E) of 100 M 2BP. GFP-tH and f-PHB-GFP show greatly reduced
PM association after 2BP treatment (B and F, respectively) and an
intracellular localization. PM association of the non-palmitoylated pro-
tein, GFP-GPI, detected by labeling for the GFP tag with anti-GFP
followed by goat anti-rabbit-cy3, was unaffected by 2BP (C and D).
Expression of the flotillin mutants Flot-C34A-HA and f-PHB-C34A-
GFP in BHK cells (G and H, respectively) resulted in an intracellular
expression pattern, suggesting that the cysteine at amino acid 34 is
important for normal PM association. Western blot indicates the rela-
tive distributions of transfected Flot-HA, Flot-C34A-HA, f-PHB-GFP,
and f-PHB-C34A-GFP in BHK crude cytosol (S) and membrane (P)
fractions after high speed centrifugation (100,000  g) (I). Flot-HA,
f-PHB-GFP, and caveolin are tightly associated with membranes. In
contrast, Flot-C34A-HA and f-PHB-C34A-GFP show a significant loss
of membrane association and concomitant partitioning into the cytoso-
lic fractions.
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domain is conserved even in prokaryotic proteins (20), suggest-
ing an extremely fundamental role for this membrane domain.
We have also identified a novel pathway by which flotillin-1
reaches the PM. The role of this trafficking pathway is unclear
but may allow highly rapid changes in flotillin-1 localization in
response to specific stimuli.
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